- Design
- Systematic review and meta-analysis of 36 studies
- Population
- 7110 patients aged 65 and over with cancer
- Primary outcome
- Accuracy for abnormal geriatric assessment; prediction of survival and toxicity
- Effect
- Overall survival HR 1.68 (1.53 to 1.84); adverse events OR 4.29 (1.39 to 13.23)
The Vulnerable Elders Survey-13 is a short self-report screen for people aged 65 and over. A JAMDA meta-analysis pooled 36 studies (7110 patients) with cancer to test how well it identifies abnormalities on comprehensive geriatric assessment and predicts outcomes.
Diagnostic accuracy for an abnormal geriatric assessment was moderate (diagnostic odds ratio 1.93). A high score predicted worse overall survival (HR 1.68, 95% CI 1.53 to 1.84), more adverse events during treatment (OR 4.29) and more dose reductions (OR 2.24), but not progression-free survival.
VES-13 is a sorting tool, not a substitute for assessment. In a busy oncology or geriatric clinic, it can identify who most needs the full assessment before chemotherapy is planned.
- Use VES-13 or a similar short screen before cancer treatment in people aged 65 and over.
- Arrange comprehensive geriatric assessment for those who screen positive, before treatment is finalised.
- Expect more toxicity and dose reductions in high scorers and plan supportive care accordingly.
- Do not use a negative screen alone to rule out vulnerability; accuracy was only moderate.
Why it matters
It gives oncology teams a quick way to find older patients likely to struggle with treatment toxicity.
Don't overread it
Accuracy was moderate; VES-13 identifies who needs assessment, it does not replace it.
The statistics, in plain English
A hazard ratio of 1.68 means death occurred about two-thirds more often over time in high scorers. A diagnostic odds ratio of 1.93 indicates modest discrimination — useful for prioritising, not for ruling in or out.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for geriatrics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free